1. Leptin and chronic kidney diseases
   Song Mao et al, 2018, Journal of Receptors and Signal Transduction CrossRef
2. Connective tissue growth factor (CTGF) from basics to clinics.
   Yasaman Ramazani et al, 2018, Matrix Biol CrossRef
3. A novel small-molecule activator of Sirtuin-1 induces autophagic cell death/mitophagy as a potential therapeutic strategy in glioblastoma
   Zhi-qiang Yao et al, 2018, Cell Death Dis CrossRef
4. SRT1720 ameliorates sodium taurocholate-induced severe acute pancreatitis in rats by suppressing NF-κB signalling
   Chenyuan Shi et al, 2018, Biomedicine & Pharmacotherapy CrossRef
5. SIRT1 Attenuates Kidney Disorders in Male Offspring Due to Maternal High-Fat Diet.
   Long T Nguyen et al, 2019, Nutrients CrossRef
6. Association of sirtuin 1 gene polymorphisms with nephrolithiasis in Eastern chinese population
   Jiebin Hou et al, 2019, Renal Failure CrossRef
7. SRT1720 retards renal fibrosis via inhibition of HIF1A/GLUT1 in diabetic nephropathy
   Weixia Han et al, 2019 CrossRef
8. The Ameliorating Effect of Plasma Protein from Tachypleus tridentatus on Cyclophosphamide-Induced Acute Kidney Injury in Mice
   Xinhuang Kang et al, 2019, Marine Drugs CrossRef
9. Resveratrol ameliorates long-term structural, functional and metabolic perturbations in a rat model of donor nephrectomy: Implication of SIRT1
   Marianne Basta et al, 2019, Journal of Functional Foods CrossRef
10. PGC‐1α, a potential therapeutic target against kidney aging
    Gayoung Lee et al, 2019, Aging Cell CrossRef
11. SIRT1 gene polymorphisms are associated with nondiabetic type 1 cardiorenal syndrome
    Jiebin Hou et al, 2019, Annals of Human Genetics CrossRef
12. Orally administered resveratrol enhances the therapeutic effect of autologous transplanted adipose-derived stem cells on rats with diabetic hepatopathy
    T.-S. Chen et al, 2019, Biotechnic & Histochemistry CrossRef
13. TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression
    Dakota L. Jones et al, 2019, J Cell Sci CrossRef
14. Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence
    Lucia Scisciola et al, 2020, Epigenetics CrossRef
15. The road ahead for health and lifespan interventions
    Marta Gonzalez-Freire et al, 2020, Ageing Research Reviews CrossRef
16. The impact of mitochondrial quality control by Sirtuins on the treatment of type 2 diabetes and diabetic kidney disease
    Jing Xu et al, 2020, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
17. Crosstalk between kidney and liver in non-alcoholic fatty liver disease: mechanisms and therapeutic approaches
    Nisha Sharma et al, 2020, Archives of Physiology and Biochemistry CrossRef
18. Exogenous pancreatic kininogenase protects against renal fibrosis in rat model of unilateral ureteral obstruction
    Ji-zhe Jin et al, 2020, Acta Pharmacol Sin CrossRef
19. Regulation of left atrial fibrosis induced by mitral regurgitation by SIRT1
    Dong Zhang et al, 2020, Sci Rep CrossRef
20. Sirt1 inhibits HG-induced endothelial injury: Role of Mff-based mitochondrial fission and F‑actin homeostasis-mediated cellular migration
    Ruijie Qin et al, 2019, Int J Mol Med CrossRef
21. Erlotinib can halt adenine induced nephrotoxicity in mice through modulating ERK1/2, STAT3, p53 and apoptotic pathways
    Ahmed M. Awad et al, 2020, Sci Rep CrossRef
22. Quercetin alleviates kidney fibrosis by reducing renal tubular epithelial cell senescence through the SIRT1/PINK1/mitophagy axis
    Tao Liu et al, 2020, Life Sciences CrossRef
23. Role of sirtuin-1 (SIRT1) in hypoxic injury in pancreatic β-cells
    Ye-Jee Lee et al, 2020, Journal of Drug Targeting CrossRef
24. Sirtuins as endogenous regulators of lung fibrosis: A current perspective
    Somnath Mazumder et al, 2020, Life Sciences CrossRef
25. Ameliorating Effect of Pentadecapeptide Derived from Cyclina sinensis on Cyclophosphamide-Induced Nephrotoxicity
    Xiaoxia Jiang et al, 2020, Marine Drugs CrossRef
26. MiR-155-5p promotes renal interstitial fibrosis in obstructive nephropathy via inhibiting SIRT1 signaling pathway
    Zhan Wang et al, 2020, Journal of Receptors and Signal Transduction CrossRef
27. Antioxidant Activity with Increased Endogenous Levels of Vitamin C, E and A Following Dietary Supplementation with a Combination of Glutathione and Resveratrol Precursors
    Priscilla Biswas et al, 2020, Nutrients CrossRef
28. CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment, normal and malignant hematopoiesis
    Roos J. Leguit et al, 2021, J. Cell Commun. Signal. CrossRef
29. Depleting microRNA-183-3p improves renal tubulointerstitial fibrosis after acute kidney injury via SIRT1/PUMA/FOXO3a deacetylation
    Hunian Li et al, 2021, Life Sciences CrossRef
30. null
    Luca Perico et al, 2021 CrossRef
31. SIRT1 attenuates renal fibrosis by repressing HIF-2α
    Peipei Li et al, 2021, Cell Death Discov. CrossRef
32. The emerging role of metabolism in fibrosis
    John Henderson et al, 2021, Trends in Endocrinology & Metabolism CrossRef
33. p53 regulated senescence mechanism and role of its modulators in age-related disorders
    Girija Pawge et al, 2021, Biochemical Pharmacology CrossRef
34. Fibrosis: Sirtuins at the checkpoints of myofibroblast differentiation and profibrotic activity
    Alberto Zullo et al, 2021, Wound Rep Reg CrossRef
35. NAD+ Homeostasis in Diabetic Kidney Disease
    Jing Xu et al, 2021, Front. Med. CrossRef
36. Sirt1 inhibits kidney stones formation by attenuating calcium oxalate-induced cell injury
    Qing-Lin Ye et al, 2021, Chemico-Biological Interactions CrossRef
37. Prospective Pharmacological Potential of Resveratrol in Delaying Kidney Aging
    Md Jamal Uddin et al, 2021, IJMS CrossRef
38. Exenatide Attenuates Obesity-Induced Mitochondrial Dysfunction by Activating SIRT1 in Renal Tubular Cells
    Yao Wang et al, 2021, Front. Endocrinol. CrossRef
39. Targeting Sirtuin1 to treat aging-related tissue fibrosis: From prevention to therapy
    Xin Han et al, 2021, Pharmacology & Therapeutics CrossRef
40. Epigenetic regulation in fibrosis progress
    Taixiong Xue et al, 2021, Pharmacological Research CrossRef
41. The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential
    Xiaoqin Zhang et al, 2021, IJMS CrossRef
42. Application of Histone Deacetylase Inhibitors in Renal Interstitial Fibrosis
    Ling Nie et al, 2020, Kidney Dis CrossRef
43. Therapeutic Effects of Sirtuin 1 Activator on Glaucoma Mice and the Regulation Mechanism of Mitogen-Activated Protein Kinase Pathway
    Yuee Zhao et al, 2022, j biomater tissue eng CrossRef
44. A scalable 3D tissue culture pipeline to enable functional therapeutic screening for pulmonary fibrosis
    Katherine A. Cummins et al, 2021, APL Bioengineering CrossRef
45. Obesity and Male Reproduction: Do Sirtuins Play a Role?
    Federica Barbagallo et al, 2022, IJMS CrossRef
46. SRT1720 plays a role in oxidative stress and the senescence of human trophoblast HTR8/SVneo cells induced by D-galactose through the SIRT1/FOXO3a/ROS signalling pathway
    Lanlan Yin et al, 2022, Reproductive Toxicology CrossRef
47. Screening and identification of key microRNAs and regulatory pathways associated with the renal fibrosis process
    Xiang Li et al, 2022, Mol. Omics CrossRef
48. Research Progress of Chinese Herbal Medicine Intervention in Renal Interstitial Fibrosis
    Xiao-Yuan Liu et al, 2022, Front. Pharmacol. CrossRef
49. As a Modulator, Multitasking Roles of SIRT1 in Respiratory Diseases
    Yunxin Zhou et al, 2022, Immune Netw CrossRef
50. p53/sirtuin 1/NF-κB Signaling Axis in Chronic Inflammation and Maladaptive Kidney Repair After Cisplatin Nephrotoxicity
    Ying Fu et al, 2022, Front. Immunol. CrossRef
51. The interaction between cellular senescence and chronic kidney disease as a therapeutic opportunity
    Jing-Li Zhao et al, 2022, Front. Pharmacol. CrossRef
52. Renal fibrosis as a hallmark of diabetic kidney disease: Potential role of targeting transforming growth factor-beta (TGF-β) and related molecules
    Jiali Tang et al, 2022, Expert Opinion on Therapeutic Targets CrossRef
53. null
    Wiwit Nurwidyaningtyas et al, 2022 CrossRef
54. Protective Effects of Carnosol on Renal Interstitial Fibrosis in a Murine Model of Unilateral Ureteral Obstruction
    Jae-Hyung Park et al, 2022, Antioxidants CrossRef
55. The sirtuin family in health and disease
    Qi-Jun Wu et al, 2022, Sig Transduct Target Ther CrossRef
56. The Mitochondrion: A Promising Target for Kidney Disease
    Cem Tanriover et al, 2023, Pharmaceutics CrossRef
57. UCP1 Alleviates Renal Interstitial Fibrosis Progression Through Oxidative Stress Pathway Mediated by SIRT3 Protein Stability
    Wei Xiong et al, 2022, SSRN Journal CrossRef
58. Sirt1 Overexpression Inhibits Fibrous Scar Formation and Improves Functional Recovery After Cerebral Ischemic Injury Through the Deacetylation of 14–3-3ζ
    Yue Chen et al, 2023, Mol Neurobiol CrossRef
59. Evaluation of in vivo and ex vivo pre-treated bone marrow-derived mesenchymal stem cells with resveratrol in streptozotocin-induced type 1 diabetic rats
    S G Khalil et al, 2023 CrossRef
60. p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis
    Zehua Ye et al, 2023, Biomedicine & Pharmacotherapy CrossRef
61. Mitochondrial Oxidative Metabolism: An Emerging Therapeutic Target to Improve CKD Outcomes
    Kranti A. Mapuskar et al, 2023, Biomedicines CrossRef
62. L‐carnitine reverses methotrexate‐induced nephrotoxicity in experimental rat model: Insight on SIRT1/PGC‐1α/Nrf2/HO‐1 axis
    Sara M. Radwan et al, 2023, J of Applied Toxicology CrossRef
63. UCP1 alleviates renal interstitial fibrosis progression through oxidative stress pathway mediated by SIRT3 protein stability
    Wei Xiong et al, 2023, J Transl Med CrossRef
64. Protein acetylation and related potential therapeutic strategies in kidney disease
    Xiang-yu Li et al, 2023, Pharmacological Research CrossRef
65. From Physiology to Pathology: The Role of Mitochondria in Acute Kidney Injuries and Chronic Kidney Diseases
    Lingge Zhang et al, 2023, Kidney Dis CrossRef
66. Therapeutic application of traditional Chinese medicine in kidney disease: Sirtuins as potential targets
    Qi Jin et al, 2023, Biomedicine & Pharmacotherapy CrossRef
67. The Molecular Basis of Male Infertility in Obesity: A Literature Review
    Biji Thomas George et al, 2023, IJMS CrossRef
68. Sirtuins in kidney health and disease
    Luca Perico et al, 2024, Nat Rev Nephrol CrossRef
69. Hirudin in the Treatment of Chronic Kidney Disease
    Sai-Ji Liu et al, 2024, Molecules CrossRef
70. The role of PI3K/Akt signaling pathway in chronic kidney disease
    Hongshuang Wang et al, 2024, Int Urol Nephrol CrossRef
71. Challenges and opportunities in obesity: the role of adipocytes during tissue fibrosis
    Qian Zhang et al, 2024, Front. Endocrinol. CrossRef